amodiaquine has been researched along with Acute Confusional Senile Dementia in 2 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gay, M | 1 |
Carato, P | 1 |
Coevoet, M | 1 |
Renault, N | 1 |
Larchanché, PE | 1 |
Barczyk, A | 1 |
Yous, S | 1 |
Buée, L | 1 |
Sergeant, N | 1 |
Melnyk, P | 1 |
Moon, M | 1 |
Jung, ES | 1 |
Jeon, SG | 1 |
Cha, MY | 1 |
Jang, Y | 1 |
Kim, W | 1 |
Lopes, C | 1 |
Mook-Jung, I | 1 |
Kim, KS | 1 |
2 other studies available for amodiaquine and Acute Confusional Senile Dementia
Article | Year |
---|---|
New phenylaniline derivatives as modulators of amyloid protein precursor metabolism.
Topics: Alzheimer Disease; Amodiaquine; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compo | 2018 |
Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model.
Topics: Aging; Alzheimer Disease; Amodiaquine; Animals; Brain; Cognition; Disease Models, Animal; Glutamic A | 2019 |